1Herbrecht R,Denning DW,Patterson TF,et al.Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[].The New England Journal of Medicine.2002
2.
3Walsh TJ,Anaissie EJ,Denning DW,et al.Treatment of Aspergil-losis:Clinical Practice Guidelines of the Infectious Diseases Socie-ty of America[].Clinical Infectious Diseases.2008
4Hope,WW,Walsh,TJ,Denning,DW.Laboratory diagnosis of invasive aspergillosis[].The Lancet Infectious Diseases.2005
5AustinJHM,,Muller NL,Friedman PJ,et al.Glossary of termsfor CTof the lung:Recommendations of the Nomenclature Committee of the Fleischner Society[].Radiology.1996
6Marr KA,Balajee SA,Mclaughlin,L,Tabouret,M,Bentsen,C,Walsh TJ.Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance[].The Journal of Infectious Diseases.2004
7Odabasi Z,Mattiuzzi G,Estey E,et al.Beta-D-glucan as a diag-nostic adjunct for invasive fungal infections:validation,cutoff development,and performance in patients with acute myeloge-nous leukemia and myelodysplastic syndrome[].Clinical Infectious Diseases.2004
8Donnelly,JP.Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go[].Clinical Infectious Diseases.2006
9Maertens J,Theunissen K,Verhoef G,et al.Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection:a prospective feasibility study[].Clinical Infectious Diseases.2005
